Standout Papers

Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of H... 1999 2026 2008 2017 2.5k
  1. Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol (1999)
    Hanna E. Bloomfield, Sander J. Robins et al. New England Journal of Medicine
  2. Effect of Systemic Glucocorticoids on Exacerbations of Chronic Obstructive Pulmonary Disease (1999)
    Dennis E. Niewoehner, Marcia L. Erbland et al. New England Journal of Medicine
  3. Relation of Gemfibrozil Treatment and Lipid Levels With Major Coronary Events (2001)
    Sander J. Robins, Dorothea Collins et al. JAMA

Immediate Impact

5 from Science/Nature 104 standout
Sub-graph 1 of 14

Citing Papers

Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease
2019 Standout
Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease
2019 Standout
65 intermediate papers

Works of Dorothea Collins being referenced

Effect of Systemic Glucocorticoids on Exacerbations of Chronic Obstructive Pulmonary Disease
1999 Standout
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
and 9 more

Author Peers

Author Last Decade Papers Cites
Dorothea Collins 1410 3229 3337 39 6.1k
Hanna E. Bloomfield 2002 3767 4601 81 8.3k
Pekka Koskinen 2535 3416 3568 69 7.4k
Matti Mänttäri 2198 3544 4069 59 8.4k
Xue-Qiao Zhao 2089 2121 3395 54 5.9k
Basil M. Rifkind 1448 3239 2594 108 6.7k
Marianne Benn 2496 3147 3951 117 8.3k
H. Schulte 2569 3155 3169 126 7.9k
Marshall B. Elam 1540 3194 3619 82 7.1k
Brian A. Ference 1514 1947 3426 66 6.0k
Guðmundur Þorgeirsson 2074 1684 2029 84 5.6k

All Works

Loading papers...

Rankless by CCL
2026